Clinical trials recruiting for Metastatic NSCLC - Non-Small Cell Lung Cancer
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Amivantamab | 1 |
| Carboplatin | 1 |
| Cemiplimab | 1 |
| Magnesiocard | 1 |
| Magnesium Diasporal | 1 |
| Paclitaxel | 1 |
| Pembrolizumab | 1 |
| Pemetrexed & Gemcitabine | 1 |
| Pemetrexed + Cisplatin /Carboplatin | 1 |
| Zoldonrasib | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Florida | 1 |
Top cities
Self-screener
Recruiting trials
- Large Granular Lymphocytes in mNSCLC Treated With Nivolumab
- Magnesium Supplementation in Advanced Non-small Cell Lung Cancer (NSCLC)
- Phase II Trial of Amivantamab Plus Monochemotherapy in Platinum Unfit NSCLC Patients With EGFR exon20 Insertion Mutations.
- Reduced-dose Carboplatin-doublet-chemotherapy + Cemiplimab vs Cemiplimab Monotherapy in Treatment Naive Older and Frail Patients With Metastatic NSCLC With PD-L1 <50%
- Study of Pembrolizumab + Pemetrexed + Platinum Chemotherapy With or Without Zoldonrasib as First Line Treatment in Metastatic Non-squamous RAS G12D-Mutated NSCLC
Related conditions
Trials recruiting for Metastatic NSCLC - Non-Small Cell Lung Cancer often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Metastatic NSCLC - Non-Small Cell Lung Cancer trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.